SAN DIEGO--(BUSINESS WIRE)--Apr. 9, 2019--
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results
for first quarter 2019 following the close of market on Thursday, April
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis
deSouza, President and Chief Executive Officer, and Sam Samad, Senior
Vice President and Chief Financial Officer, will host a conference call
with analysts, investors, and other interested parties to discuss
financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern
Time) on Thursday, April 25, 2019. Interested parties may access the
live teleconference through the Investor Relations section of Illumina’s
website under the “company” tab at www.illumina.com.
Alternatively, individuals can access the call by dialing 1 (844)
647-5490 or 1 (615) 247-0295 outside North America, both with conference
A replay of the conference call will be posted on Illumina’s website
after the event and will be available for at least 30 days following.
Illumina is improving human health by unlocking the power of the genome.
Our focus on innovation has established us as the global leader in DNA
sequencing and array-based technologies, serving customers in the
research, clinical and applied markets. Our products are used for
applications in the life sciences, oncology, reproductive health,
agriculture and other emerging segments. To learn more, visit www.illumina.com and
View source version on businesswire.com: https://www.businesswire.com/news/home/20190409005992/en/
Source: Illumina, Inc.
Jacquie Ross, CFA